STOCK TITAN

Beneficient-A SEC Filings

BENF Nasdaq

Welcome to our dedicated page for Beneficient-A SEC filings (Ticker: BENF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Beneficient’s alternative-asset business model packs pages of specialized terminology—TEFFI trust structures, AltAccess platform metrics, and loan-to-value disclosures—into every SEC filing. Finding where management discusses liquidity risk or how Ben Custody books revenue can take hours. Stock Titan solves this by delivering AI-powered summaries that turn Beneficient SEC filings into clear insights you can act on.

Whether you need the Beneficient annual report 10-K simplified, the latest Beneficient quarterly earnings report 10-Q filing, or a sudden Beneficient 8-K material events explained, our platform updates in real time as each document hits EDGAR. Investors tracking Beneficient insider trading Form 4 transactions can set instant alerts and view Beneficient Form 4 insider transactions real-time alongside easy-to-read charts. Our AI also maps pages that detail TEFFI capital ratios, technology spending, and segment revenue, so understanding Beneficient SEC documents with AI feels effortless.

Use this page to:

  • Scan Beneficient earnings report filing analysis for cash-flow timing across Ben Liquidity and Ben Custody
  • Review the Beneficient proxy statement executive compensation to gauge incentives driving growth
  • Monitor Beneficient executive stock transactions Form 4 before major announcements

All filing types—10-K, 10-Q, 8-K, S-1, DEF 14A and more—are covered, timestamped, and linked to concise AI commentary. No more hunting through PDFs; get Beneficient SEC filings explained simply and make informed decisions with confidence.

Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Filing
Rhea-AI Summary

Beneficient (BENF) describes a technology-enabled fiduciary business built around its AltAccess platform to provide liquidity and primary capital for alternative assets. The company reports historical transaction activity of approximately $1.2 billion and states that Ben Liquidity's loan portfolio had a carrying value of $244.0 million with ExAlt Loan Collateral valued at $291.4 million (NAV $259.1 million) as of March 31, 2025. ExAlt Loans have earned stated interest of about $427.7 million through that date.

The filing discloses material operational and financial risks: a net loss of $0.8 million for fiscal 2025 and an accumulated deficit of $2.0 billion; approximately $117.9 million of debt outstanding as of March 31, 2025; identified material weakness in internal control over financial reporting; notice of Nasdaq noncompliance; HCLP has alleged events of default and sought collateral; and ongoing litigation involving the founder and related parties. The company also outlines growth initiatives including an ExchangeTrust Product Plan targeting up to $5 billion of fiduciary financings and automation of ~77% of transaction steps via AltAccess.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.67%
Tags
annual report
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.67%
Tags
current report
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.71%
Tags
current report
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.58%
Tags
current report
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Filing
Rhea-AI Summary

Hatteras Investment Partners, LP reports beneficial ownership of 562,749 shares of Beneficient Class A common stock, representing approximately 6.7% of the class. The filing states Hatteras is a Delaware limited partnership acting as an investment adviser with sole voting and dispositive power over these shares, which are held for one or more advisory clients. The filing notes that Hatteras Master Fund, LP has an interest equal to 5.6% of the class. Hatteras disclaims direct beneficial ownership except to the extent of any pecuniary interest and confirms the securities are held in the ordinary course of business and not to influence control of the issuer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Form 3 Highlights

Interim CEO James G. Silk filed his initial statement of beneficial ownership for Beneficient (BENF) as of 20 Jul 2025.

  • Direct ownership: 2,397 Class A shares. This total includes 282 shares issuable from 225 REUs (2018 plan) and 1,204 shares from 1,204 RSUs (2023 plan). Remaining tranches vest through 1 Apr 2026 and 1 Sep 2027.
  • Derivative interests: 1,362 BCH Class S units linked to Preferred A-0 accounts and 5,449 Class S units linked to Preferred A-1 accounts. Both series are convertible 1-for-1 into BENF Class A shares; conversions are subject to price floors of at least $840 and, for A-1 units, a 20% annual cap until 2029 unless price triggers lift the limit.
  • All derivative units are currently convertible and have no stated expiration. Exchange requires 61-day notice and trading-window compliance.

No purchases or sales were reported; the filing solely discloses existing holdings. Operational, financial and capital structure impacts are immaterial in the near term, but the disclosure underscores incentive alignment between management and shareholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Beneficient (BENF) Form 4 shows Global Head of Organizations & Distribution Jeff Welday acquired 30,687 Class A shares on 21 Jul 2025 through an immediately-vesting restricted stock unit (RSU) grant made under the 2023 Equity Incentive Plan. The shares were issued at $0 cost and coded “A” (acquisition), indicating they were awarded, not purchased on the open market.

Following the settlement, Welday’s direct beneficial ownership rises to 172,394 shares. This total includes prior equity awards: 61,592 RSUs granted 14 Jan 2025, 28,320 RSUs granted 15 Jul 2023, multiple REU awards from 2018-2022, and a 1,670-share RSU grant dated 16 Jan 2025. No derivative securities or sales were reported.

The filing reflects routine executive compensation and signals increased insider alignment but only modest dilution to existing shareholders. Because no open-market buying or selling occurred, immediate trading impact is expected to be minimal.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Beneficient-A (BENF)?

The current stock price of Beneficient-A (BENF) is $0.4751 as of October 10, 2025.

What is the market cap of Beneficient-A (BENF)?

The market cap of Beneficient-A (BENF) is approximately 5.5M.
Beneficient-A

Nasdaq:BENF

BENF Rankings

BENF Stock Data

5.50M
8.11M
13.47%
15.55%
9.95%
Asset Management
Finance Services
Link
United States
DALLAS